Funded Tech Companies
Immusoft
Immusoft is a biopharmaceutical company, located in Seattle. Venture capital investment was provided by California Institute for Regenerative Medicine, Alexandria Venture Investments and DEFTA Partners.
Company Overview
Company Name
Immusoft
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
454 N 34th St.
Seattle, WA 98103
USA
Seattle, WA 98103
USA
Phone
Website
Email Address
Company Background Information
Overview
Immusoft's mission is to develop a breakthrough autologous cell therapy platform for treating a variety of human diseases through our proprietary Immune System Programming (ISP) technology. ISP technology can effectively re-program a patient's own cells to become miniature drug factories in the body.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/31/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Ainsworth
Chief Scientific Officer
Robert Hayes
VP - Bus. Development
Cam Gallagher
VP - Bus. Development
Scott McIvor
VP - Regulatory Affairs
Monika Swietlicka
Company Investors
- California Institute for Regenerative Medicine
- Alexandria Venture Investments
- DEFTA Partners
- RBV Capital
- Breakout Capital
- Mesa Verde Venture Partners
- Founders Fund (Peter Thiel)
- Technium Partners
- 600 Mile Challenge Fund
- Private Investors (Timothy Draper)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs